** Shares of Integral Diagnostics IDX.AX fall 29% to A$2.030, their lowest levels since February 20, 2024
** Stock is currently the top loser on ASX All Ordinaries Index .AORD
** The medical imaging services provider reports HY loss attributable of A$396,000 ($251,420.40), compared with a loss of A$66.8 million last year
** Co also reports HY operating NPAT of A$9.8 million, missing consensus estimate of A$11.1 million
** Expects replacement and growth capex for FY25 to be between A$60 million and A$65 million
** About 4.9 million shares change hands, 5.6 times the 30-day average of 870,753
** Stock down 28.9% YTD, including current session's moves
($1 = 1.5751 Australian dollars)
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。